TP53 and neoplasm: TP53 gene, which encodes human p53 protein, is mutated in over 50% of all human cancers,3 with p53 signalling pathway disruptions observed in over 80% of tumour samples, profoundly impacting malignancy, metastasis, therapeutic resistance, and clinical prognosis.4